Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 12:34 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1513–1536 of 1,748 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Cardiovascular Risks Clear all

Conditions: Myocardial Infarction (MI), Stroke
Interventions: Smartphone application Antshrike; Device
Lead sponsor: Stanford University; Other
Eligibility: 40 Years to 79 Years
Enrollment: 300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Stanford, California

Conditions: Diffuse Large B-cell Lymphoma (DLBCL), Cardiotoxicity, Lymphoma
Interventions: Dexrazoxane, Dexrazoxane placebo, Doxorubicin, Liposomal Doxorubicin, Cyclophosphamide, Vincristine, Prednisone, Rituximab, Polatuzumab Vedotin; Drug
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2035
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Metabolic Syndrome, Overweight and Obesity, Cardiovascular Risk Factor
Interventions: Not listed
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 4 Years to 21 Years
Enrollment: 477 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2017
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: HIV, Inflammation
Interventions: Zinc gluconate; Dietary Supplement
Lead sponsor: Grace McComsey; Other
Eligibility: 18 Years and older
Enrollment: 52 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Asthma, Hypertension, Cardiovascular Risk Factor, Insulin Resistance, Stress Disorders, Post-Traumatic, Exposure to Toxic Dust
Interventions: Not listed
Lead sponsor: NYU Langone Health; Other
Eligibility: 12 Years to 20 Years
Enrollment: 402 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: New York, New York

Conditions: Coronary Disease, Diabetes Mellitus, Non-Insulin-Dependent
Interventions: Reiki; Procedure
Lead sponsor: National Center for Complementary and Integrative Health (NCCIH); NIH
Eligibility: 20 Years to 80 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1998 – 2004
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Coronary Arterial Disease (CAD), Percutaneous Coronary Intervention (PCI)
Interventions: Prasugrel, Clopidogrel; Drug
Lead sponsor: University of Florida; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Myocardiopathies, Ischemia, Myocardial, Arrythmia, Death, Sudden, Cardiac
Interventions: Not listed
Lead sponsor: Thomas Jefferson University; Other
Eligibility: 18 Years and older
Enrollment: 63 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Vascular Diseases
Interventions: Placebo, BMS-582949, Atorvastatin, Statin; Other · Drug
Lead sponsor: Bristol-Myers Squibb; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 17
States / cities: Chiefland, Florida • Jacksonville, Florida • Tampa, Florida + 13 more

Conditions: Schizophrenia, Cardiovascular Disease
Interventions: Not listed
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 10 Years to 55 Years
Enrollment: 38 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2012
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Cardiovascular Risk, Cardiovascular Prevention
Interventions: CV Prevention Choice Tool, Implementation Facilitation Strategies; Behavioral
Lead sponsor: Mayo Clinic; Other
Eligibility: 40 Years to 75 Years
Enrollment: 112,127 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 4
States / cities: Marietta, Georgia • Rochester, Minnesota • Grand Forks, North Dakota + 1 more

Conditions: Menopause, Depression, Heart Disease in Women, Stress
Interventions: Trier Social Stress Test; Behavioral
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 44 Years to 55 Years · Female only
Enrollment: 41 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Type 1 Diabetes, Obesity
Interventions: Semaglutide, Placebo; Drug
Lead sponsor: Viral N. Shah; Other
Eligibility: 18 Years to 65 Years
Enrollment: 115 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 4
States / cities: Aurora, Colorado • West Des Moines, Iowa • Detroit, Michigan + 1 more

Conditions: Multiple Myeloma, Chronic Lymphocytic Leukemia
Interventions: Screening; Other
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Acute Myocardial Infarction, Acute Coronary Syndrome
Interventions: high-sensitivity cardiac troponin testing; Diagnostic Test
Lead sponsor: Fred Apple; Other
Eligibility: 21 Years and older
Enrollment: 1,559 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Multiple Myeloma, Primary Amyloidosis
Interventions: Melphalan, Stem Cell Infusion, Questionnaires, Granulocyte-colony stimulating factor (G-CSF), Apheresis; Drug · Procedure · Behavioral
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 60 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2016
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Neoplasms
Interventions: Rivaroxaban, Placebo; Drug
Lead sponsor: Janssen Research & Development, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 841 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 70
States / cities: Phoenix, Arizona • Tucson, Arizona • Little Rock, Arkansas + 67 more

Conditions: Heart Failure
Interventions: Observational; Other
Lead sponsor: Medtronic; Industry
Eligibility: Not listed
Enrollment: 2,200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2028
U.S. locations: 51
States / cities: Chandler, Arizona • Little Rock, Arkansas • Chula Vista, California + 44 more

Conditions: Heart Failure
Interventions: Not listed
Lead sponsor: Thomas Jefferson University; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2011
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Chronic Kidney Disease, Diabetes, Hypertension, High BP, Type 2 Diabetes
Interventions: Collaborative Model of Primary care and Subspecialty care; Other
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years to 85 Years
Enrollment: 18,268 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2022
U.S. locations: 4
States / cities: Farmington, Connecticut • Arlington, Texas • Dallas, Texas

Conditions: Hypertension
Interventions: Digital heath tool, Low-intensity recommendation, High-intensity recommendation; Other
Lead sponsor: National Bureau of Economic Research, Inc.; Other
Eligibility: 18 Years and older
Enrollment: 3,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Posttraumatic Stress Disorder, Insomnia
Interventions: Personalized sleep intervention; Behavioral
Lead sponsor: Howard University; Other
Eligibility: 18 Years to 35 Years
Enrollment: 168 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Heart Failure
Interventions: Referral to MTM Pharmacist; Other
Lead sponsor: Geisinger Clinic; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Danville, Pennsylvania

Conditions: HIV Infection, Cardiovascular Disease Risk
Interventions: Pravastatin, Lisinopril; Drug
Lead sponsor: Hennepin Healthcare Research Institute; Other
Eligibility: 40 Years and older
Enrollment: 37 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Search by objective public record fields.

Smartphone Application to PREDICT Real-Time Cardiovascular Risk for Heart Attack and Stroke

The CARDIOPROTECT Trial

Pediatric Metabolic Syndrome Study

Zinc Supplementation and Cardiovascular Risk in HIV

World Trade Center Adolescent Health Study

Effects of Reiki on Painful Neuropathy and Cardiovascular Risk Factors

Dual Antiplatelet Therapy Escalation From Standard-dose Clopidogrel to Low-Dose Prasugrel in Patients With High Bleeding and Ischemic Risk Undergoing PCI: A Prospective, Randomized Pharmacodynamic Study (TAILOR-BLEED-2)

Extracellular Matrix Marker of Arrhythmia Risk (EMMA)

Efficacy Study of p38 Kinase Inhibitor to Treat Patients With Atherosclerosis

Direct Measurements of Cardiometabolic Risk in Treated Schizophrenia Patients

Implementing Shared Decision Making (SDM) For Individualized CV Prevention (SDM4IP)

Depression, Aging, Stress and Heart Health Study

ADJUnct Semaglutide Treatment in Type 1 Diabetes

Biomarker for Infection Risk in CLL and MM

MERITnI - Mindray-hs-cTnI Assay: Analytical and Clinical Evaluation for the Diagnosis and RIsk AssessmenT of Myocardial InfarctIon.

Trial of Two Stem Cell Doses To Reduce Transplant Induced Symptom Burden

A Study to Evaluate the Efficacy and Safety of Rivaroxaban Venous Thromboembolism (VTE) Prophylaxis in Ambulatory Cancer Participants

Personalized Therapy Study - HFRS (TriageHF) Post Approval Study

Heart Failure and Risk of Re-Admissions Determined by Abnormal REVEAL Parameters

Improving Chronic Disease Management With Pieces

Combining AI/ML and Personalized Medicine to Reduce Cardiovascular Risk

Stress, Sleep and Cardiovascular Risk

Risk and Benefit Informed MTM Pharmacist Intervention in Heart Failure

Cardiovascular Prevention for Persons With HIV